BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kalsheker NA. α 1 -Antitrypsin deficiency: best clinical practice. J Clin Pathol 2009;62:865-9. [DOI: 10.1136/jcp.2008.063495] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Hoàng TH, Phạm TN, Nguyễn GK, Lê QH. A rare variant of α 1 antitrypsin mutations detected in Vietnamese children with liver disease. Ann Clin Biochem 2013;50:339-44. [PMID: 23766346 DOI: 10.1177/0004563212473443] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Lefkowitch JH. Advances in hepatobiliary pathology: update for 2010. Clin Liver Dis 2010;14:747-62. [PMID: 21055694 DOI: 10.1016/j.cld.2010.07.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Balduyck M, Odou MF, Zerimech F, Porchet N, Lafitte JJ, Maitre B. Diagnosis of alpha-1 antitrypsin deficiency: modalities, indications and diagnosis strategy. Rev Mal Respir 2014;31:729-45. [PMID: 25391508 DOI: 10.1016/j.rmr.2014.06.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
4 Leßig J, Reibetanz U, Schönberg M, Neundorf I. Efficient inhibition of human leukocytic elastase by means of α1-antitrypsin/peptide complexes. Cytometry A 2013;83:461-71. [PMID: 23529890 DOI: 10.1002/cyto.a.22270] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
5 Quinn PM, Dunne DW, Moore SC, Pleass RJ. IgE-tailpiece associates with α-1-antitrypsin (A1AT) to protect IgE from proteolysis without compromising its ability to interact with FcεRI. Sci Rep 2016;6:20509. [PMID: 26842628 DOI: 10.1038/srep20509] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
6 Khodayari N, Oshins R, Holliday LS, Clark V, Xiao Q, Marek G, Mehrad B, Brantly M. Alpha-1 antitrypsin deficient individuals have circulating extracellular vesicles with profibrogenic cargo. Cell Commun Signal 2020;18:140. [PMID: 32887613 DOI: 10.1186/s12964-020-00648-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Obeidat M, Wain LV, Shrine N, Kalsheker N, Soler Artigas M, Repapi E, Burton PR, Johnson T, Ramasamy A, Zhao JH, Zhai G, Huffman JE, Vitart V, Albrecht E, Igl W, Hartikainen AL, Pouta A, Cadby G, Hui J, Palmer LJ, Hadley D, McArdle WL, Rudnicka AR, Barroso I, Loos RJ, Wareham NJ, Mangino M, Soranzo N, Spector TD, Gläser S, Homuth G, Völzke H, Deloukas P, Granell R, Henderson J, Grkovic I, Jankovic S, Zgaga L, Polašek O, Rudan I, Wright AF, Campbell H, Wild SH, Wilson JF, Heinrich J, Imboden M, Probst-Hensch NM, Gyllensten U, Johansson Å, Zaboli G, Mustelin L, Rantanen T, Surakka I, Kaprio J, Jarvelin MR, Hayward C, Evans DM, Koch B, Musk AW, Elliott P, Strachan DP, Tobin MD, Sayers I, Hall IP; SpiroMeta Consortium. A comprehensive evaluation of potential lung function associated genes in the SpiroMeta general population sample. PLoS One 2011;6:e19382. [PMID: 21625484 DOI: 10.1371/journal.pone.0019382] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 3.4] [Reference Citation Analysis]
8 Lin HC, Kasi N, Quiros JA. Alpha1-Antitrypsin Deficiency: Transition of Care for the Child With AAT Deficiency into Adulthood. Curr Pediatr Rev 2019;15:53-61. [PMID: 30421678 DOI: 10.2174/1573396314666181113094517] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
9 Lusch A, Kaup M, Marx U, Tauber R, Blanchard V, Berger M. Development and analysis of alpha 1-antitrypsin neoglycoproteins: the impact of additional N-glycosylation sites on serum half-life. Mol Pharm 2013;10:2616-29. [PMID: 23668542 DOI: 10.1021/mp400043r] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
10 Siekmeier R. Lung deposition of inhaled alpha-1-proteinase inhibitor (alpha 1-PI) - problems and experience of alpha1-PI inhalation therapy in patients with hereditary alpha1-PI deficiency and cystic fibrosis. Eur J Med Res 2010;15 Suppl 2:164-74. [PMID: 21147646 DOI: 10.1186/2047-783x-15-s2-164] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
11 Casas F, Blanco I, Martínez MT, Bustamante A, Miravitlles M, Cadenas S, Hernández JM, Lázaro L, Rodríguez E, Rodríguez-frías F, Torres M, Lara B. Actualización sobre indicaciones de búsqueda activa de casos y tratamiento con alfa-1 antitripsina por vía intravenosa en pacientes con enfermedad pulmonar obstructiva crónica asociada a déficit de alfa-1 antitripsina. Archivos de Bronconeumología 2015;51:185-92. [DOI: 10.1016/j.arbres.2014.05.008] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 6.3] [Reference Citation Analysis]
12 Abboud RT, Nelson TN, Jung B, Mattman A. Alpha1-antitrypsin deficiency: a clinical-genetic overview. Appl Clin Genet 2011;4:55-65. [PMID: 23776367 DOI: 10.2147/TACG.S10604] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
13 Janciauskiene S, Wallmark A, Piitulainen E, Köhnlein T, Welte T, Sveger T. Performance of enhanced liver fibrosis plasma markers in asymptomatic individuals with ZZ α1-antitrypsin deficiency. Eur J Gastroenterol Hepatol 2011;23:716-20. [PMID: 21617532 DOI: 10.1097/MEG.0b013e328347daaf] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
14 Greene DN, Procter M, Grenache DG, Lyon E, Bornhorst JA, Mao R. Misclassification of an apparent alpha 1-antitrypsin “Z” deficiency variant by melting analysis. Clinica Chimica Acta 2011;412:1454-6. [DOI: 10.1016/j.cca.2011.03.032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
15 Janciauskiene SM, Bals R, Koczulla R, Vogelmeier C, Köhnlein T, Welte T. The discovery of α1-antitrypsin and its role in health and disease. Respir Med 2011;105:1129-39. [PMID: 21367592 DOI: 10.1016/j.rmed.2011.02.002] [Cited by in Crossref: 179] [Cited by in F6Publishing: 167] [Article Influence: 16.3] [Reference Citation Analysis]
16 Khodayari N, Wang RL, Oshins R, Lu Y, Millett M, Aranyos AM, Mostofizadeh S, Scindia Y, Flagg TO, Brantly M. The Mechanism of Mitochondrial Injury in Alpha-1 Antitrypsin Deficiency Mediated Liver Disease. IJMS 2021;22:13255. [DOI: 10.3390/ijms222413255] [Reference Citation Analysis]
17 Casas F, Blanco I, Martínez MT, Bustamante A, Miravitlles M, Cadenas S, Hernández JM, Lázaro L, Rodríguez E, Rodríguez-frías F, Torres M, Lara B. Indications for Active Case Searches and Intravenous Alpha-1 Antitrypsin Treatment for Patients With Alpha-1 Antitrypsin Deficiency Chronic Pulmonary Obstructive Disease: An Update. Archivos de Bronconeumología (English Edition) 2015;51:185-92. [DOI: 10.1016/j.arbr.2014.12.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
18 Kok KF, Willems HL, Drenth JP. The cut-off value of 100 mg/dl is insufficient to detect heterozygous alpha-1 antitrypsin-deficient liver disease patients. Liver Int 2010;30:491-2. [PMID: 19968780 DOI: 10.1111/j.1478-3231.2009.02179.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
19 Koepke J, Dresel M, Schmid S, Greulich T, Beutel B, Schmeck B, Vogelmeier CF, Janciauskiene S, Koczulla AR. Therapy with plasma purified alpha1-antitrypsin (Prolastin®) induces time-dependent changes in plasma levels of MMP-9 and MPO. PLoS One 2015;10:e0117497. [PMID: 25635861 DOI: 10.1371/journal.pone.0117497] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
20 Koc G, Akgul K, Yilmaz Y, Dirik A, Un S. The effects of cigarette smoking on prostate-specific antigen in two different age groups. Can Urol Assoc J 2013;7:E704-7. [PMID: 24282461 DOI: 10.5489/cuaj.358] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
21 Renduchintala K, Pabbathi S, Nanjappa S, Ramsakal A, Greene J. A Case of Alpha-1 Antitrypsin Deficiency and Organizing Pneumonia. Cureus 2020;12:e12078. [PMID: 33489496 DOI: 10.7759/cureus.12078] [Reference Citation Analysis]
22 Janciauskiene S, Welte T. Well-Known and Less Well-Known Functions of Alpha-1 Antitrypsin. Its Role in Chronic Obstructive Pulmonary Disease and Other Disease Developments. Annals ATS 2016;13:S280-8. [DOI: 10.1513/annalsats.201507-468kv] [Cited by in Crossref: 47] [Cited by in F6Publishing: 32] [Article Influence: 7.8] [Reference Citation Analysis]